Concepedia

Alexandre V. Hirayama

AV

22

Publications

2.5K

Citations

19

H-Index

2018

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

University of British Columbia

Seattle Children's Hospital

Oregon Health & Science University

Alexandre V. Hirayama is an author at Fred Hutch Cancer Center specializing in medicine, oncology, and autoimmunity.

ORCID

Top concepts

Publications per year

2018–2025

22

Publications

22

Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapy

Kevin A. Hay, Jordan Gauthier, Alexandre V. Hirayama et al. · Blood · 2019 · 389 citations · Full text

Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells

Ana Cordeiro, Evandro D. Bezerra, Alexandre V. Hirayama et al. · Biology of Blood and Marrow Transplantation · 2019 · 335 citations · Full text

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells

Alexandre V. Hirayama, Jordan Gauthier, Kevin A. Hay et al. · Blood · 2019 · 324 citations · Full text

Feasibility and efficacy of CD19-targeted CAR T cells with concurrent ibrutinib for CLL after ibrutinib failure

Jordan Gauthier, Alexandre V. Hirayama, Janaki Purushe et al. · Blood · 2020 · 309 citations · Full text

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Jordan Gauthier, Evandro D. Bezerra, Alexandre V. Hirayama et al. · Blood · 2020 · 204 citations · Full text

Rows per page

1–5 of 22